NCT06899048

Brief Summary

evaluate the degree of association, and the predictive accuracy of the REPS (as a predictive tool) compared with the TOFr as a quantitative assessment tool for (rNMB) in surgical patients in the early postoperative phase. The TOFr will be measured at 0, 15, 30, 45, and 60 min after extubation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
91

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 27, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 27, 2025

Status Verified

October 1, 2024

Enrollment Period

1.2 years

First QC Date

March 21, 2025

Last Update Submit

March 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • correlation between residual neuromuscular block risk prediction score and train of four

    1 hour

Interventions

it is a clinical tool designed to estimate the likelihood of residual neuromuxcular blockade in postoperative patients

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who will be scheduled to undergo elective surgical procedures requiring the use of neuromuscular blocking drugs.

You may qualify if:

  • Age group 18-65 years old
  • Both genders
  • Patients with American Society of Anesthesiologist physical status classification of 1 or 2.

You may not qualify if:

  • Patients who are less than 18 years old or more than 65 years old.
  • Patients with planned scheduled recovery in the intensive care unit or if more than 10 minutes had elapsed since tracheal extubation until NMB monitoring at the PACU.
  • Patients on medications that interfere with muscle activity.
  • Known allergy to neuromuscular blocking agents.
  • Pregnancy or suspected pregnancy.
  • Neuro-muscular diseases.
  • Patients refusing to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University Hospitals

Asyut, 71111, Egypt

RECRUITING

MeSH Terms

Conditions

Muscle Hypotonia

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Mahmoud A Faisal, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

March 21, 2025

First Posted

March 27, 2025

Study Start

August 1, 2024

Primary Completion

October 1, 2025

Study Completion

April 1, 2026

Last Updated

March 27, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations